Table 2.
Parameter | Number | Percent |
---|---|---|
Male gender | 155 | 58 |
Female gender | 114 | 42 |
Adenocarcinoma | 192 | 71 |
Non-adenocarcinoma | 77 | 29 |
Extracranial metastases | 176 | 65 |
No extracranial metastases | 93 | 35 |
Single brain metastasis | 54 | 20 |
2–4 brain metastases | 86 | 32 |
>4 brain metastases | 129 | 48 |
EGFR or ALK positive | 19 | 7 |
Age <70 years | 200 | 74 |
Age ≥70 years | 69 | 26 |
KPS <70 | 52 | 19 |
KPS 70 | 70 | 26 |
KPS 80 | 50 | 19 |
KPS 90–100 | 97 | 36 |
Upfront whole brain radiotherapya | 193 | 72 |
Upfront neurosurgery | 57 | 21 |
Upfront radiosurgery | 16 | 6 |
Upfront stereotactic fractionated radiotherapy | 3 | 1 |
Supportive care alone | 0 | 0 |
KPS Karnofsky performance status
aincludes patients with delayed (salvage) neurosurgery, radiosurgery, fractionated re-irradiation